Unknown

Dataset Information

0

<i>In vivo</i> adeno-associated virus-mediated LDLR/PCSK9 intervention for familial hypercholesterolemia.

ABSTRACT:

SUBMITTER: Han Z 

PROVIDER: S-EPMC12281168 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

&lt;i&gt;In vivo&lt;/i&gt; adeno-associated virus-mediated LDLR/PCSK9 intervention for familial hypercholesterolemia.

Han Zeyu Z   Tan Cheng C   Ai Jianzhong J   Zhu Ye Y  

Genes & diseases 20250410 6

Similar Datasets

Unknown Functional Analysis of 3'UTR Variants at the &lt;i&gt;LDLR&lt;/i&gt; and &lt;i&gt;PCSK9&lt;/i&gt; Genes in Patients with Familial Hypercholesterolemia.
| S-EPMC11918801 | biostudies-literature
Unknown Methylation status of &lt;i&gt;LDLR&lt;/i&gt;, &lt;i&gt;PCSK9&lt;/i&gt; and &lt;i&gt;LDLRAP1&lt;/i&gt; is associated with cardiovascular events in familial hypercholesterolemia.
| S-EPMC11370914 | biostudies-literature
Unknown Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia.
| S-EPMC3620484 | biostudies-literature
Unknown Identification of a novel LDLR p.Glu179Met variant in Thai families with familial hypercholesterolemia and response to treatment with PCSK9 inhibitor.
| S-EPMC10957951 | biostudies-literature
Unknown LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL.
| S-EPMC10956282 | biostudies-literature
Unknown Patients With <i>LDLR</i> and <i>PCSK9</i> Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia.
| S-EPMC7955325 | biostudies-literature
Unknown Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia.
| S-EPMC8090480 | biostudies-literature
Unknown LDLR gene's promoter region hypermethylation in patients with familial hypercholesterolemia.
| S-EPMC10247769 | biostudies-literature
Unknown Characterization of selected LDLR substitutions in patients with familial hypercholesterolemia.
| S-EPMC12681971 | biostudies-literature
Unknown &lt;i&gt;Proprotein Convertase Subtilisin&lt;/i&gt;/&lt;i&gt;Kexin Type 9&lt;/i&gt; (&lt;i&gt;PCSK9&lt;/i&gt;) Inhibitor Therapy Reduces the Level of DNA Damage in Patients with Heterozygous Familial Hypercholesterolemia.
| S-EPMC12607971 | biostudies-literature